Skip to main content

Animations

MJFF Publications

5041 - 5050 of 6420 Results
Title
Year
  • Year
  • 2009
  • 2019
  • 2016
  • 2021
  • 2020
  • 2021
  • 2019
  • 2022
  • 2018
  • 2024
  • Summary Details
    OPEN
    Title: Ceramide and neurodegeneration: Susceptibility of neurons and oligodendrocytes to cell damage and death
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jns.2008.12.010
    Citation Count: 225
  • Summary Details
    OPEN
    Title: Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH‐EXAMINER as a potential clinical trial endpoint
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.jalz.2019.01.012
    Citation Count: 43
  • Summary Details
    OPEN
    Title: The melanoma‐linked “redhead” MC1R influences dopaminergic neuron survival
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.24852
    Citation Count: 49
  • Summary Details
    OPEN
    Title: Molecular Mechanisms Underlying Synaptic and Axon Degeneration in Parkinson’s Disease
    Journal Name: Frontiers in Cellular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fncel.2021.626128
    Citation Count: 81
  • Summary Details
    OPEN
    Title: Three-Plane–assembled Deep Learning Segmentation of Gliomas
    Journal Name: Radiology: Artificial Intelligence
    Publisher: Radiological Society of North America (RSNA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1148/ryai.2020190011
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Differential cardiopulmonary monitoring system for artifact-canceled physiological tracking of athletes, workers, and COVID-19 patients
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1126/sciadv.abg3092
    Citation Count: 91
  • Summary Details
    OPEN
    Title: Transportation innovation to aid Parkinson disease trial recruitment
    Journal Name: Contemporary Clinical Trials Communications
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.conctc.2019.100449
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry Approach to Correlate Local Structure and Aggregation in α-Synuclein
    Journal Name: Analytical Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1021/acs.analchem.2c03183
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Investigation of serotonergic Parkinson's disease-related covariance pattern using [11C]-DASB/PET
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2018.05.022
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Biallelic NDUFA13 variants lead to a neurodevelopmental phenotype with gradual neurological impairment
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcae453
    Citation Count: 2
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.